Oncodesign Services, a leading CRO in drug discovery and preclinical services
Innovative services & quality deliverables to accelerate your research program
Oncodesign Services is a contract research organization (CRO) specialized in drug discovery whose mission is to contribute to the discovery of innovative therapies against cancers and serious diseases with high medical needs.
Find out more about what we can offer you depending on the stage of development of your drug discovery project!
- Target Identification
- Target Validation
- Small Molecule
- Molecular RadioTherapy
- POC Oncology
- POC Inflammation
- DMPK – Bioanalysis
Our Therapeutic Areas
Our latest news
Oncodesign Services and Veritas In Silico Inc. announced that they have entered into a Memorandum of Understanding to respond to the needs of pharmaceutical companies seeking to develop innovative small molecule drugs targeting messenger RNA.
[EN] Preclinical Models for the Identification of Chemotherapy Predictive Signatures in Pancreatic Cancer
Join the featured speakers to learn how they utilized preclinical models such as primary cell cultures, patient-derived xenografts, and patient-derived organoids to develop unbiased predictive RNA-based signatures.